These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2860655)

  • 1. The effect of dopamine antagonists in spontaneous and tardive dyskinesia.
    Fog R
    Psychopharmacology Suppl; 1985; 2():118-21. PubMed ID: 2860655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia].
    Kozian R; Friederich M
    Psychiatr Prax; 2007 Jul; 34(5):253-4. PubMed ID: 17597439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
    Braun A; Mouradian MM; Mohr E; Fabbrini G; Chase TN
    J Neurol Neurosurg Psychiatry; 1989 May; 52(5):631-5. PubMed ID: 2567345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two cases of tardive Tourette syndrome].
    Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia with Tourette-like syndrome.
    Seeman MV; Patel J; Pyke J
    J Clin Psychiatry; 1981 Sep; 42(9):357-8. PubMed ID: 6944306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
    Ringwald E
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):294-8. PubMed ID: 33397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging treatments: replacement therapy with choline or lecithin in neurological diseases.
    Barbeau A
    Can J Neurol Sci; 1978 Feb; 5(1):157-60. PubMed ID: 148319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa and receptor sensitivity modification in tardive dyskinesia.
    Casey DE; Gerlach J; Bjørndal N
    Psychopharmacology (Berl); 1982; 78(1):89-92. PubMed ID: 6128757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia.
    Alpert M; Friedhoff AJ; Diamond F
    Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives.
    Kulkarni SK; Naidu PS
    Drugs Today (Barc); 2003 Jan; 39(1):19-49. PubMed ID: 12669107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet dopamine uptake in Huntington's chorea and Gilles de la Tourette's syndrome: effect of haloperidol.
    Butterworth RF; Gonce M; Barbeau A
    Can J Neurol Sci; 1977 Nov; 4(4):285-8. PubMed ID: 145893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine depleters in the treatment of hyperkinetic movement disorders.
    Jankovic J
    Expert Opin Pharmacother; 2016 Dec; 17(18):2461-2470. PubMed ID: 27819145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation and pharmacological treatment of Gilles de la Tourette's syndrome and other hyperkinesias.
    Regeur L
    Acta Neurol Scand Suppl; 1992; 137():48-50. PubMed ID: 1357907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium carbonate in the treatment of movement disorders. A critical review.
    Yassa R; Ananth J
    Int Pharmacopsychiatry; 1980; 15(5):301-8. PubMed ID: 6114936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia following risperidone treatment in Tourette's syndrome.
    Thomas N; Swamidhas P; Russell S; Angothu H
    Neurol India; 2009; 57(1):94-5. PubMed ID: 19305093
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review.
    Goldman MB; Luchins DJ
    Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine antagonist and agonist treatment of tardive dyskinesia.
    Bjørndal N; Casey D; Gerlach J
    Adv Biochem Psychopharmacol; 1980; 24():541-5. PubMed ID: 6105800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.